ISRG vs VRTV: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Intuitive Surgical, Inc. · Healthcare
$388.97
+45.0% upside to fair value
Grade B
High Quality
VS
Veritiv Corporation · Industrials
$169.99
-43.3% upside to fair value
Grade D
QuantHub Verdict
ISRG has more upside to fair value
(+45.0%).
VRTV trades at a lower forward P/E
(7.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
VRTV |
| Current Price |
$388.97 |
$169.99 |
| Fair Value Estimate |
$564.01 |
$96.38 |
| Upside to Fair Value |
+45.0%
|
-43.3%
|
| Market Cap |
$137.8B |
$2.3B |
| Forward P/E |
46.5x
|
7.1x
|
| EV / EBITDA |
31.4x
|
5.4x
|
| Price / Sales |
13.0x
|
0.3x
|
| Price / FCF |
48.6x
|
10.0x
|
| Revenue Growth YoY |
+23.0%
|
-19.0%
|
| Gross Margin |
66.3%
|
22.7%
|
| Operating Margin |
30.5%
|
5.9%
|
| Return on Equity |
17.0%
|
48.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.06%
|
9.99%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
Veritiv Corporation operates as a distributor primarily in packaging, facility solutions, and print markets, with a business quality characterized by scale and network density rather than proprietary products or pricing power. The company has undergone significant transformation under CEO Salvatore A. Abbate, including a take-private transaction by Clayton, Dubilier & Rice in 2023 and a strategic…
Accumulation Zones
| Metric |
ISRG |
VRTV |
| Zone Low |
$423.01 |
$72.28 |
| Zone High |
$479.41 |
$81.92 |
| In Buy Zone? |
Yes
|
No
|